Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Conway

Showing results (51-60 of 146) with videos related to

Pageof 15
Sort By:
Antiviral Therapy|November 13, 2004
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenzFrank van Leth, Brian Conway, Hector Laplumé, et al.
Infectious Diseases and Therapy|July 20, 2023
Assessment of Drug-Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and SimulationsDwaipayan Mukherjee, Michelle Collins, Douglas E Dylla, et al.
Canadian Liver Journal|August 22, 2022
Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT)Brian Conway, Dan Smyth, Réjean Thomas, et al.
The Journal of Physical Chemistry. B|August 11, 2016
Rotational Dynamics in Ionic Liquids from NMR Relaxation Experiments and Simulations: Benzene and 1-Ethyl-3-MethylimidazoliumChristopher A Rumble, Anne Kaintz, Sharad K Yadav, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|April 26, 2005
Update of the Drug Resistance Mutations in HIV-1: 2005Victoria A Johnson, Francoise Brun-Vezinet, Bonaventura Clotet, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 11, 2017
Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected PatientsMark Nelson, Rafael Rubio, Adriano Lazzarin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2011
A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathyDavid B Clifford, David M Simpson, Stephen Brown, et al.
The Open Virology Journal|May 15, 2009
Clinical implications of mutations at reverse transcriptase codon 135 on response to NNRTI-based therapyHarout K Tossonian, Jesse D Raffa, Jason Grebely, et al.
Plos One|April 23, 2011
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adultsCurtis Cooper, Anona Thorne, Marina Klein, et al.
Statistical Methods in Medical Research|June 17, 2015
Accounting for dropout reason in longitudinal studies with nonignorable dropoutCamille M Moore, Samantha MaWhinney, Jeri E Forster, et al.
Pageof 15

Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
Antiviral Therapy|November 13, 2004
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenzFrank van Leth, Brian Conway, Hector Laplumé, et al.
Infectious Diseases and Therapy|July 20, 2023
Assessment of Drug-Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and SimulationsDwaipayan Mukherjee, Michelle Collins, Douglas E Dylla, et al.
Canadian Liver Journal|August 22, 2022
Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT)Brian Conway, Dan Smyth, Réjean Thomas, et al.
The Journal of Physical Chemistry. B|August 11, 2016
Rotational Dynamics in Ionic Liquids from NMR Relaxation Experiments and Simulations: Benzene and 1-Ethyl-3-MethylimidazoliumChristopher A Rumble, Anne Kaintz, Sharad K Yadav, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|April 26, 2005
Update of the Drug Resistance Mutations in HIV-1: 2005Victoria A Johnson, Francoise Brun-Vezinet, Bonaventura Clotet, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 11, 2017
Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected PatientsMark Nelson, Rafael Rubio, Adriano Lazzarin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2011
A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathyDavid B Clifford, David M Simpson, Stephen Brown, et al.
The Open Virology Journal|May 15, 2009
Clinical implications of mutations at reverse transcriptase codon 135 on response to NNRTI-based therapyHarout K Tossonian, Jesse D Raffa, Jason Grebely, et al.
Plos One|April 23, 2011
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adultsCurtis Cooper, Anona Thorne, Marina Klein, et al.
Statistical Methods in Medical Research|June 17, 2015
Accounting for dropout reason in longitudinal studies with nonignorable dropoutCamille M Moore, Samantha MaWhinney, Jeri E Forster, et al.
Pageof 15